The problem
Bringing a new medicine to market is estimated to cost around $2.7 billion, and a large share of drugs are delayed or fail approval because of documentation errors rather than the science. Manufacturers still lean on legacy systems and manual processes to assemble regulatory paperwork, pulling data from multiple systems to satisfy different country-specific requirements, which turns approval into a slow, error-prone mess of documents.
What we did
RoboReg automates pharmaceutical regulatory compliance. We developed a tool that gathers the required data and assembles regulatory documentation accurately, replacing manual paperwork across country-specific requirements so submissions are faster and cleaner. Fewer documentation-driven delays mean drugs can reach the market sooner.
The outcome
A faster, lower-cost route to bringing medicines to market, turning regulatory paperwork from a bottleneck into an automated step.